SCHEMBL3201162

SCHEMBL3201162

Cc1cccc(-c2cccc(C(=O)O)c2)c1C

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 2/20 0.59
AKR1C3 P42330 2/20 0.55
AKR1C2 P52895 2/20 0.55
KMO O15229 2/20 0.55
FOLH1 Q04609 2/20 0.49
RXRA P19793 2/20 0.49
RXRB P28702 2/20 0.49
TYMS P04818 1/20 0.48
DDT P30046 1/20 0.48
PTGER1 P34995 1/20 0.47
TTR P02766 1/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
KEAP1 Q14145 1/20 0.46
FFAR1 O14842 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3852306 0.98 NR1H4 (0.58) NR1H4AKR1C3AKR1C2KMOFOLH1
SCHEMBL3716976 0.88 AKR1C3 (0.57) NR1H4AKR1C3AKR1C2KMOFOLH1
SCHEMBL2995452 0.88 NR1H4 (0.74) NR1H4AKR1C3AKR1C2KMOFOLH1
Benzoic Acid SCHEMBL28364522 0.88 NR1H4 (0.50) NR1H4AKR1C3AKR1C2KMORXRA
SCHEMBL30516532 0.87 CNR2 (0.56) NR1H4KMOLMNAFFAR1
SCHEMBL29116857 0.87 CNR2 (0.56) NR1H4KMOLMNAFFAR1
SCHEMBL10884048 0.86 NR1H4 (0.49) NR1H4AKR1C3AKR1C2FFAR1
SCHEMBL23581248 0.85 NR1H4 (0.58) NR1H4AKR1C3AKR1C2KMOFOLH1
SCHEMBL3135455 0.85 PARP1 (0.53) NR1H4
SCHEMBL28372111 0.84 AKR1C3 (0.63) NR1H4AKR1C3AKR1C2KMOFOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674938-B2 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof KISSEI PHARMACEUTICAL CO., LTD. (JP) 2010-03-09 US disclosed
US-20090030218-A1 Method For Producing Aminoalcohol Derivative Having Biphenyl Group KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-01-29 US disclosed
US-20080076826-A1 POLYMORPHIC CRYSTAL OF 4'-{2-[ (1S, 2R) - 2- HYDROXY -2- (4-HYDROXYPHENYL) -1- METHYLETHYLAMINO] ETHOXY} - 3 - ISOPROPYL-3', 5' -DIMETHYLBIPHENYL - 4 - CARBOXYLIC ACID HYDROCHLORIDE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2008-03-27 US disclosed
EP-1697339-A1 3-(4-BENZYLOXYPHENYL)PROPANOIC ACID DERIVATIVES Takeda Pharmaceutical Company Limited (JP) 2006-09-06 EP disclosed
EP-1611089-A2 HYDROXYETHYLAMINE COMPOUNDS HAVING ASP2 INHIBITORY ACTIVITY FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LIMITED (GB) 2006-01-04 EP disclosed
WO-2005063729-A1 3-(4-BENZYLOXYPHENYL)PROPANOIC ACID DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-07-14 WO disclosed
WO-2004080376-A2 HYDROXYETHYLAMINE COMPOUNDS HAVING ASP2 INHIBITORY ACTIVITY FOR THE TREATMENT OF ALZHEIMER’S DISEASE GLAXO GROUP LIMITED (GB) 2004-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090030218-A1 Method For Producing Aminoalcohol Derivative Having Biphenyl Group ALDH7A1, DDC, ADH5 NR1H4 494/4885AKR1C3 96/4885AKR1C2 105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.